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Available online 29 March 2016Cell-penetrating peptides (CPPs) have emerged as a potentially powerful tool for drug delivery due to their ability
to efﬁciently transport a whole host of biologically active cargoes into cells. Although concerted efforts have shed
some light on the cellular internalization pathways of CPPs, quantiﬁcation of CPP uptake has proved problematic.
Here we describe an experimental approach that combines two powerful biophysical techniques, ﬂuorescence-
activated cell sorting (FACS) and ﬂuorescence correlation spectroscopy (FCS), to directly, accurately and precisely
measure the cellular uptake of ﬂuorescently-labeled molecules. This rapid and technically simple approach is
highly versatile and can readily be applied to characterize all major CPP properties that normally requiremultiple
assays, including amount taken up by cells (in moles/cell), uptake efﬁciency, internalization pathways, intracel-
lular distribution, intracellular degradation and toxicity threshold. The FACS–FCS approach provides a means for
quantifying any intracellular biochemical entity, whether expressed in the cell or introduced exogenously and
transported across the plasma membrane.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Since the discovery of theﬁrst cell-penetrating peptides (CPPs) – the
TAT peptide (derived from the HIV-1 transcription-activating protein)
[1,2] and penetratin (pAntp, from the Antennapedia homeodomain, a
Drosophila transcription factor) [3] – over two decades ago, CPPs have
been used extensively to mediate the cellular delivery of coupled
cargoes with high efﬁciency, both in vitro and in vivo [4,5]. The wide
range of cargoes delivered by CPPs include proteins, peptides, antisense
oligonucleotides, small interfering RNAs (siRNAs), λ phages, liposomes,
quantum dots, and even 40 nm magnetic iron oxide nanoparticles [4].
Consequently, CPPs have emerged as a potentially powerful tool for
drug delivery.
Effective utilization of CPPs for drug delivery requires understanding
their cellular internalization mechanisms as well as quantifying their
uptake. Although concerted efforts have shed light on the cellular
internalization pathways of CPPs [6–8], quantiﬁcation of CPP uptake
has so far proved problematic. Themost common approaches for quan-
tifying CPP uptake involve measuring cell-associated ﬂuorescencek University Abu Dhabi, PO Box
Emirates.
b).
. This is an open access article underintensity of cells treated with a ﬂuorescently-labeled CPP and compar-
ing it to the signal from cells treated with a reference peptide or mole-
cule. This is often done with a ﬂuorescence plate reader, ﬂow
cytometry, or confocal microscopy [9–12]. Although these methods
are straightforward and relatively fast, they compare relative ﬂuores-
cence intensities and therefore only qualitatively measure uptake.
Another approach involves quantifying the uptake indirectly
through a readout generated by a delivered cargo, for instance ﬂuores-
cent protein expression [13]. A more direct method for measuring
cellular internalization of CPPs employs high performance liquid chro-
matography (HPLC), where a concentration gradient of organic solvent
separates elements with different hydrophobic properties to quantify
the amount of peptide in cell lysates [14]. Matrix-assisted laser
desorption/ionization-time of ﬂight mass spectrometry (MALDI-TOF
MS) has also been used to measure peptide concentrations directly by
suspending the sample in a matrix that is then vaporized and ionized
by a laser, with the particles distinguished by the time of ﬂight through
an electric ﬁeld [15].
However, none of the methods currently available can distinguish
healthy cells from unhealthy or dead ones, and so cannot account for
peptide cytotoxicity when measuring per-cell concentrations. Even
small numbers of dead cells can confound uptake measurements, as
cell membranes become porous after death but often stay intact enoughthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lated intracellularly.
The experimental approach reported here combines two powerful
biophysical techniques: ﬂuorescence-activated cell sorting (FACS) and
ﬂuorescence correlation spectroscopy (FCS). This rapid and technically
straightforward approach is highly versatile and can determine impor-
tant CPP parameters that normally requiremultiple assays: intracellular
amount, uptake efﬁciency and internalization pathways.
Notably, the approach has novel capabilities. While most of the
current methods for quantifying CPP uptake only measure total cell
uptake, the FACS–FCS approach can differentiate CPPs that localize
to the cytosol from those trapped in endocytic compartments, and
can in turn measure the cytosolic delivery efﬁciency. And unlike cur-
rent methods, FACS–FCS distinguishes between healthy and dead
cells. Consequently, this approach can be used to accurately quantify
the maximum tolerable amounts of CPPs or their cargoes for the cell.
Additionally, FACS–FCS can determine the fractions of CPPs that are
degraded intracellularly. These are all crucial considerations when
utilizing CPPs for drug design and development.
Further, the FACS–FCS approach offers several additional advantages
over previously published methods. The combination of FACS and FCS
affords the approach greater accuracy and precision, while making it
faster and technically simpler than most of the current methods. And
since FACS and FCS arewidely available atmost academic and industrial
institutions, this approach is cheaper and more accessible for many
researchers. Finally, althoughwe use FACS–FCS here to quantify CPP up-
take, it can readily be applied to proteins, peptides, nucleic acids, drugs,
or nanoparticles. This generality means that our versatile, rapid and
technically straightforward experimental approach should be of broad
interest to molecular and cell biologists, biochemists, biophysicists and
pharmacologists.
2. Materials and methods
2.1. Materials
CPPswere synthesized by Selleck Chemicals (Houston, TX) using stan-
dard Fmocmethods and puriﬁed in house by reverse-phaseHPLC (Waters
2535 QGM HPLC). N-terminally biotinylated penetratin (pAntp) was
purchased from AnaSpec (Fremont, CA). Alexa Fluor 488 and Alexa Fluor
488-succinimidylester, quantum dot (QD625) streptavidin conjugate,
70 kDa neutral dextran-tetramethylrhodamine, cholera toxin subunit B
(recombinant) Alexa Fluor 555 conjugate, transferrin (from human
serum) Alexa Fluor 546 conjugate, and wheat germ agglutinin (WGA)
Alexa Fluor 594 conjugate (cell membrane marker), were all purchased
from Molecular Probes (Carlsbad, CA). 4′,6-diamidino-2-phenylindole
(DAPI), propidium iodide (PI), sodium azide, 2-deoxy-D-glucose, and
the endocytosis inhibitors – ammonium chloride, chlorpromazine,
methyl-β-cyclodextrin, ﬁlipin and cytochalasin D – were from Sigma.
2.2. Peptide labeling
Amine coupling was used to attach Alexa Fluor 488-succinimidylester
to the N-terminus of CPPs as previously described [16]. Brieﬂy, ~0.5 mg
of lyophilized peptide was dissolved in 800 μL of 10 mM sodium phos-
phate, pH 7.2. An approximate 10-fold molar excess of dye (~0.1 mg)
was added as powder, and the samplewas gently vortexed and incubat-
ed on a rotator for 2 h at room temperature. Separation of labeled and
un-labeled peptide was done by reverse-phase HPLC, extent of labeling
was assessed usingmass spectrometry (Agilent 6538 QToF LC/MS), and
concentration of labeled protein was determined using absorbance at
494 nm (ε= 73000 M−1 cm−1).
N-terminally biotinylated pAntp was labeled with quantum dot
(QD625) streptavidin conjugate according to themanufacturer’s proto-
col. Brieﬂy, 1 μL of 1 μM QD625 was mixed with 2 μL of 2 mg/mL
biotinylated pAntp in 197 μL PBS (pH 7.4) and incubated for 1 h.Concentration of QD625-labeled pAntp was veriﬁed using FCS (see the
Fluorescence correlation spectroscopy (FCS) section).
2.3. Experimental methods
The FACS–FCS approach involves threemajor steps: cell preparation
and treatment with CPPs, sorting the cells into populations according to
CPP uptake, and ﬁnally lysing the cells and quantifying the internalized
peptide.
2.3.1. Cell preparation and treatment
HeLa cells (ATCC No. CCL-2) were cultured in 5% CO2 in DMEM
(Sigma) supplemented with 10% FBS (GE Healthcare Life Sciences,
Logan, UT), 4 mM L-glutamine and 1% penicillin/streptomycin (all
from Sigma). Once the cells reached ~90% conﬂuence, they were
split (using 0.25% trypsin-EDTA, Sigma) and plated at a density of
1 × 106 cells/well in a 6-well plate (Falcon BD). The seeding density de-
pends on the cell line, and the cells should not exceed 90% conﬂuence, as
a high percentage of healthy cells is necessary for obtaining accurate
uptake efﬁciencies. As uptake depends on peptide-to-cell ratio [17],
each experiment should have the same number of cells.
After culturing for 48 h, the culturemediumwas replaced with 2mL
incubation medium (DMEM containing 1 μM ﬂuorescently-labeled
CPP), and incubated for 2 h at 37 °C and 5% CO2. To verify the peptide
concentration, 1 μL of the incubation medium was diluted to give a
ﬁnal peptide concentration of 10–20 nM, and ﬂuorescence correlation
spectroscopy (FCS) was used to measure the number of peptide
molecules in the focal volume and hence the concentration (see the
Fluorescence correlation spectroscopy (FCS) section).
To study the CPP internalization pathways, the cells were incubated
at 4 °C, preincubatedwith 10mMsodiumazide in the presence of 6mM
2-deoxy-D-glucose for 1 h to deplete cellular ATP, or pretreatedwith en-
docytosis inhibitors: 40 mM ammonium chloride, 10 μM chlorproma-
zine, 5 mM methyl-β-cyclodextrin, 4 μM ﬁlipin or 10 μM cytochalasin
D. Note: as the effective concentrations of inhibitors depend on the
cell lines and densities used, the inhibitors should be titrated and used
at non-toxic concentrations.
Following the treatments, the medium was removed and the cells
were washed twice with 2 mL PBS. The cells were dissociated from
the wells using 1 mL 0.25% trypsin-EDTA (5 min at 37 °C and 5% CO2)
and confocal microscopy was used to verify that all extracellular and
membrane-bound peptide was removed during the trypsin treatment
(Supplementary Fig. S1). Thereafter, 4 mL cell culture medium was
added to inactivate the trypsin, the cells were centrifuged at 100 ×g
for 5min at 4 °C, and the supernatant was removed. Finally, the cell pel-
let was resuspended in 2 mL of fresh phenol red-free DMEM, and the
total number of cells in the pellet was determined using an automated
cell counter (BIO-RAD TC10).
2.3.2. Fluorescence-activated cell sorting (FACS)
FACS [18]was used to rapidly sort the CPP-treated cell samplewith a
high degree of accuracy and reproducibility. In FACS a cell suspension is
entrained in a narrow, rapidly ﬂowing stream of droplets, each contain-
ing a single cell. The droplets are electrostatically sorted, one by one,
based on a number of attributes, including ﬂuorescence signal, cell
size and granularity. The ﬂuorescence signal guarantees that only cells
that have taken up peptide are considered, and also provides a very
rough measure of uptake that can later be used to corroborate results.
Cell size and granularity ensure that only healthy cells are collected,
thereby removing the confounding effects of dead or unhealthy cells.
Consequently, this approach also allows the experimenter to measure
peptide toxicity. Using FACS has the added beneﬁt of providing an
accurate cell count to later calculate the exact amount of peptide
taken up per cell.
FACS (BD FACSAria III, BD Biosciences) was used to sort 500,000
healthy cells per experiment. The cells were sorted according
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ulation with a strong ﬂuorescence signal was isolated, ensuring that it
has a narrow distribution on the FSC/SSC plot to eliminate dead cells
and debris (Supplementary Fig. S2). To determine the toxicity thresh-
old, populations of cells that have taken up the peptide were stained
with DAPI/PI (1 μM for 10 min) and further sorted into live/dead sub-
populations, using the DAPI (live cells) and PI (dead cells) signals, and
the fractions of the live/dead subpopulations relative to the total
number of cells in that population was determined.
Following sorting, the volumes of the different populations were
measured and the populations were centrifuged at 100 ×g for 5 min,
4 °C, to pellet the cells. The supernatant was then removed and the
pellet was resuspended in 100 μL lysis buffer (CellLytic™, Sigma)
and incubated for 1 h on ice. Finally, the lysate was diluted 10 fold
in PBS.
The cytosolic fraction was isolated as previously described [19].
Brieﬂy, following sorting and pelleting of cells that have taken up
the peptide, the pellet was resuspended in 500 μL ice cold isotonic
buffer (250mM sucrose, 50 mM Tris–HCl pH 7.4, 5 mMMgCl2, prote-
ase and phosphatase inhibitor cocktails; all from Sigma) in a glass
centrifuge tube. Cells were homogenized for 30 s on ice using
a tight-ﬁtting Teﬂon pestle attached to a Potter S homogenizer
(Sartorius, Göttingen, Germany) set to 150 rpm, and lysis was veri-
ﬁed by phase contrast light microscopy. The homogenate was then
sedimented by centrifugation on a table-top ultracentrifuge at
100,000 ×g for 30 min at 4 °C. Finally, the supernatant (cytosolic
fraction) was collected.
2.3.3. Fluorescence correlation spectroscopy (FCS)
FCS was used to measure the exact amount of CPPs taken up by the
cells in the lysate. FCS is a quantitative technique with single molecule
sensitivity that measures ﬂuorescence intensity ﬂuctuations when a
small number of ﬂuorescently labeled molecules diffuse through a
small (∼1.6 femtoliter) focal volume (Supplementary Fig. S3A and B).
Autocorrelation (self-similarity) of the signal accurately determines
the diffusion dynamics and the number of ﬂuorescently labeled mole-
cules in the sampling volume (Supplementary Fig. S3C). Thus FCS can
be used to directly measure intracellular ﬂuorophore concentrations
in the nanomolar range. Measurements of diffusion also directly report
on changes in the size of the molecule of interest due to, for instance,
degradation, aggregation or binding. Moreover, FCS possesses the ad-
vantage of being fast and easy to calibrate, which makes it ideal for
quantifying cellular uptake.
FCSmeasurementswere done on a home-built FCS system equipped
with the appropriate ﬁlter sets and a high numerical aperture (NA) ob-
jective for FCS (e.g. 60× or 100×, water or oil immersion). The laser
power was adjusted to 20–100 μW. 50 μL of a 5 nM solution of Alexa
488 dye was placed on amicroscope slide and the optimal objective po-
sition for FCS was located (the detector was used to ﬁnd the upper slide
surface, i.e. the planewith highest signal, and the focal pointwasmoved
10 μmabove the upper slide surface). Data points were acquired for 30 s
with an avalanche photodiode detector (APD) and the autocorrelation
curve calculated using a correlator (ALV-7004/USB). The autocorrela-
tion curve was then ﬁt to the following function to determine focal
volume radiiωx,y,z, given the concentration and the diffusion coefﬁcient,
D, of the dye (D depends on the dye and the experimental conditions,
such as the solvent viscosity and the temperature; for Alexa 488 in
water at 25 °C, D= 435 μm2/s) [20]:
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where G(0) is the inverse of the number of molecules, N, present in the
focal volume, and τD is the average diffusion time a molecule takes totransit the focal volume. The relation between the diffusion coefﬁcient,
D, and τD is given by:
D ¼ ω
2
xy
4τD
ð2Þ
The focal volumewas calibrated over awide range of concentrations
(ideally, this should be done at the start of each new experiment).
Solutions of 2.5, 5, 10, 25, 50 and 100 nM Alexa 488 were prepared in
buffer, and for each solution 50 μL was placed on a slide keeping the
droplet radius as small as possible. The number of molecules in the
focal volume, N, was determined using Eq. (1) and plotted as a function
of the known dye concentration and a linear ﬁt performed (Supplemen-
tary Fig. S3D). The focal volume was then determined by dividing the
slope of the linear ﬁt by a correction factor. This correction factor is
derived from converting the concentration (in nM) to number of
molecules per femtoliter (using: number of molecules per volume =
molar concentration × Avogadro's number) and corresponds to
1 nM= 0.6 molecules per femtoliter.
To measure the CPP concentration in the cell lysates, each sample
was centrifuged at 300×g for 10 s, 25 °C, immediately prior tomeasure-
ment, and 50 μL was pipetted onto a microscope slide. The number of
molecules in the volume, N, and the diffusion coefﬁcient, D, were
determined using Eq. (1).
For samples containing peptide particles of different sizes (and
therefore different diffusion coefﬁcients), e.g. as a result of intracellular
peptide degradation, the autocorrelation curve was instead ﬁt to the
following multiple-component function [21]:
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Xn
i¼1
f i
1þ τ
τD;i
  

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ ωxyωz
 2
 τ
τD;i
  s ð3Þ
to determine the number of particles, N, the diffusion time, τD,i, and the
fractional population, fi, of n different diffusion particles with∑fi = 1,
using the focal volume determined with the Alexa 488 dye and Eq. (1).
Nwas divided by the focal volume determined previously to obtain
the peptide concentration. Finally, the number of sorted cells and vol-
ume of the lysate solution was used to determine the amount of inter-
nalized CPP per cell, while the initial peptide concentration and cell
number were used to determine the uptake efﬁciency.
3. Results and discussion
The rapid and technically straightforward experimental approach
reported here is highly versatile and can readily be used to determine
all the major properties of CPPs that are important for their drug
delivery applications. These properties include amount taken up by
cells (in moles/cell), uptake efﬁciency, mechanism of cellular internali-
zation, intracellular distribution, intracellular degradation and cytotox-
icity threshold.
3.1. Quantiﬁcation of CPP uptake
The concentration calibration curve performed in buffer (Supple-
mentary Fig. S3D) was repeated in cell lysates to determine whether
binding to cellular components could distort the concentration mea-
surements. Increasing concentrations of Alexa 488 were diluted in
HeLa cell lysates and the number of molecules in the focal volume, N,
was determined using Eq. (1) and plotted as a function of known dye
concentration (Fig. 1A). The linear relation between N and known con-
centration clearly shows that no signiﬁcant binding takes place between
the dye molecules and cellular components in the lysates.
We applied FACS–FCS to measure the cellular internalization of
penetratin (pAntp), one of the most widely studied CPPs [4], into HeLa
Fig. 1. Quantiﬁcation of cellular uptake of CPPs. (A) Calibration curve in HeLa cell lysates. Increasing concentrations of Alexa 488 were diluted in HeLa cell lysates and the number of
molecules in the focal volume, N, was determined from the autocorrelation curves (left) using Eq. (1). N was then plotted as a function of the known dye concentration (right).
(B, C) Comparison of cellular uptake of related CPPs. 1 × 106 HeLa cells were treated with 1 μM Alexa 488-labeled CPPs for 2 h. (B) Confocal images of cellular uptake of pAntp
(left panel) and PAS–pAntp (right panel). Scale bar = 10 μm. (C) Following peptide incubation, cells were washed and trypsinized and confocal microscopy was used to conﬁrm
removal of all membrane-bound peptide. The cells were sorted using ﬂuorescence-activated cell sorting (FACS) according to intracellular ﬂuorescence signal, with the forward vs side
scatter (FSC vs SSC) analysis used to discard dead cells and debris. Finally, the CPP-positive cells were lysed and FCS was used to measure the precise number of internalized CPPs. The
cell uptake can be presented as either (left) the absolute number of internalized CPPs (expressed in moles/cell) or (right) the uptake efﬁciency of the CPPs relative to the initial peptide
concentration exposed to the cells. Error bars represent standard error across three or more independent trials.
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succinimidylester [16] or quantum dots (QD625). We also quantiﬁed
cellular uptake of pAntp sequences that were covalently coupled either
N- or C-terminally to a penetration accelerating sequence (PAS) [23],
PAS–pAntp or pAntp–PAS, respectively, and labeled with Alexa Fluor
488 (Table 1). Coupling of the short PAS segment (FFLIPKG) to CPPs
has been shown to enhance their intracellular delivery and cytosolic
release [23].
We found that the uptake of Alexa 488 labeled pAntp was 1.7 ±
0.3 × 10−18 moles/cell (Fig. 1C). Similar uptake was observed for the
QD625 labeled peptide, indicating that the amount of pAntp taken up
by the cells is not affected by the nature of ﬂuorophore used to label
the peptide. Covalently coupling PAS to the C-terminus of pAntp
(pAntp–PAS) enhanced uptake 4-fold compared to pAntp (Fig. 1C),
whereas coupling PAS N-terminal to pAntp (PAS–pAntp) lead to
substantial enhancement in cellular internalization (Fig. 1B), with the
uptake approximately 15-fold of pAntp (Fig. 1C).
Similar effects of PAS on the cellular internalization of another CPP,
octaarginine, were reported in a previous study [23]. However, that
study used FACS and confocal microscopy to provide relative measures
of intracellular ﬂuorescence intensities, whereas we use a more sensi-
tive technique, FCS, to directly measure uptake. Thus, this rapid andTable 1
CPPs characterized using FACS–FCS.
Peptide Sequence References
pAntp A488-RQIKIWFQNRRMKWKK [5]
pAntp–PAS A488-RQIKIWFQNRRMKWKKGKPILFF –
PAS–pAntp A488-FFLIPKGRQIKIWFQNRRMKWKK –
QD625-pAntp QD625-RQIKIWFQNRRMKWKK [22]straightforward approach can directly measure the number of moles
of CPP per cell, and in turn determine the uptake efﬁciency, precisely
and accurately down to the low nanomolar range, which is the expected
physiological range for CPP uptake.
3.2. Cellular uptake mechanisms of CPPs
The FACS–FCS experimental approach can readily delineate the
contribution of active processes such as endocytosis and passive,
energy-independent mechanisms (e.g. pore-formation) to the cellular
internalization of CPPs (Fig. 2). Both active and passive mechanisms of
uptake have been reported for CPPs [24–26]. Further, in the case of an
active uptake mechanism FACS–FCS can be used, in conjunction with
endocytosis inhibitors, to determine the contribution of different
endocytic routes to the uptake.
Lowering the temperature to 4 °C, where all energy-dependent up-
take processes are inhibited, resulted in near complete inhibition of
pAntp uptake into HeLa cells (Fig. 2A and Supplementary Fig. S4B).
Likewise, depleting the cellular ATP pool by preincubation of the cells
with sodium azide and deoxyglucose [27,28] led to a substantial reduc-
tion in cellular internalization of pAntp (Supplementary Fig. S5A). Taken
together, these results indicate that the cellular internalization of the
peptide is largely through an active, energy-dependent uptake mecha-
nism. This is supported by the observation that treatment with ammo-
nium chloride, a lysosomotropic agent that inhibits the acidiﬁcation of
internal vesicles such as late endosomes and lysosomes, considerably
reduced the amount of internalized pAntp (Fig. 2A and Supplementary
Fig. S4C).
In order to determinewhether this energy-dependent uptakemech-
anism involves a speciﬁc endocytic pathway, the cells were pretreated
with endocytosis inhibitors (Fig. 2A). As a control, we veriﬁed the
Fig. 2.Determination of CPP cellular uptakemechanisms. 1 × 106HeLa cellswere incubated at 4 °C to inhibit all energy-dependent processes, orwere pre-treatedwith speciﬁc endocytosis
inhibitors for 1 h. The inhibitors used were: 40 mM ammonium chloride (acidiﬁcation of endocytic vesicles), 10 μM chlorpromazine (chlor; clathrin-dependent endocytosis), 5 mM
methyl-β-cyclodextrin (lipid raft-mediated endocytosis), 4 μM ﬁlipin (caveolae-dependent endocytosis), or 10 μM cytochalasin D (cyto D; macropinocytosis). Cells were then treated
for 2 h with 1 μM (A) pAntp or (B) PAS–pAntp labeled with Alexa 488. Following peptide incubation, cells were washed, trypsinized and sorted using FACS. Finally, peptide uptake
was quantiﬁed by FCS (S.E., n = 3).
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their effect on the cellular uptake of established endocytosis markers:
transferrin-Alexa 546 (clathrin-mediated endocytosis), cholera toxin B
subunit-Alexa 555 (caveolae-dependent endocytosis), and 70 kDa neu-
tral dextran-tetramethylrhodamine (macropinocytosis) [8,29,30]. The
results are summarized in Supplementary Fig. S6A. Additionally, we
conﬁrmed that all the inhibitors did not affect cell viability at the
concentrations used (Supplementary Fig. S6B).
First, we inhibited clathrin-mediated endocytosis, the best charac-
terized endocytosis pathway, using chlorpromazine, which inhibits
clathrin-coated pit formation [31]. Treatment with chlorpromazine re-
sulted in a marked reduction in the amount of internalized pAntp.
Next, the cells were treated with methyl-β-cyclodextrin to remove
cholesterol from the plasma membrane, which disrupts several lipid
raft-mediated endocytic pathways, including caveolae-dependent en-
docytosis and macropinocytosis [32–34]. Disruption of lipid rafts by
methyl-β-cyclodextrin had a negligible effect on the cellular uptake of
pAntp, indicating that peptide internalization is lipid raft-independent.
This was conﬁrmed by treating cells with ﬁlipin, an inhibitor of lipid
raft-mediated caveolae endocytosis [32,35], which again had little effect
on the uptake of the peptide. On the other hand, treatment with
cytochalasin D, a speciﬁc inhibitor of F-actin elongation involved in
macropinocytosis [36], substantially reduced the amount of internalized
pAntp (Fig. 2A and Supplementary Fig. S4D). Similar effects were
observed for the pAntp variant that exhibited the highest uptake
efﬁciency, PAS–pAntp (Fig. 2B and Supplementary Fig. S5B). Taken
together these results show that cellular uptake of pAntp and its
variants occurs primarily through clathrin-dependent endocytosis and
macropinocytosis. These results are in agreement with previously pub-
lished studies, with internalization by both clathrin-dependent endocy-
tosis and macropinocytosis reported for pAntp [5], and underline the
robustness of the approach.
It should be noted that cellular uptake by various mechanisms has
been reported for CPPs. The particular CPP cellular internalization
mechanism appears to be highly dependent on peptide concentration.
At the lowpeptide concentrations used in this study (i.e. 1–2 μM), endo-
cytosis was shown to be the primary route of entry for pAntp and other
CPPs; at higher concentrations (generally N 10 μM), cellular uptake was
observed to occur through direct translocation via energy-independent
pathways [37,38]. Cellular uptake pathways of CPPs are also likely to be
inﬂuenced by other experimental parameters, such as cell line, incuba-
tion time, presence or absence of serum, as well as the characteristics of
a coupled cargo (including a ﬂuorophore used to label the peptide) and
the coupling strategy [7,8,39,40]. We are currently investigating theinﬂuence of all of these parameters on the cellular uptake pathways of
the CPPs used in this study.
3.3. Intracellular distribution of CPPs
An important criterion for assessing the drug delivery potential of
CPPs is the efﬁciency with which they escape from endosomes and
lysosomes and localize to the cytosol. However, most of the current
methods for quantifying CPP uptake only measure total cell uptake. In
contrast, the approach reported here can readily differentiatemolecules
in the cytosol from those trapped in endocytic compartments, and can
in turn measure the cytosolic delivery efﬁciency.
To determine the intracellular distributions of the CPPs in HeLa cells,
the cytosolic fractions were isolated from cells that had taken up the
peptides by homogenization of the cells followed by ultracentrifuga-
tion. FCS was then used to quantify the amount of CPPs that localize
to the cytosol (Fig. 3A). We found that virtually all of the intracellular
pAntp is trapped in endocytic compartments, with only 3.3 ±
0.8 × 10−20 moles/cell (or ~2% of internalized pAntp) reaching the cy-
tosol. Interestingly, in a recent study using FCS measurements in live
cells the cytosolic delivery efﬁciency of another widely studied CPP,
the HIV-1 TAT-derived peptide, was determined to be 2% of the total
amount of peptide taken up the cells [19]. On the other hand, the PAS
coupled peptides exhibited a much higher cytosolic delivery efﬁciency,
with 1.0 ± 0.2 × 10−18 and 7.4 ± 0.9 × 10−18 moles/cell of pAntp–PAS
and PAS–pAntp, respectively, trafﬁcking to the cytosol from the
endocytic pathway (Fig. 3A). This corresponds to ~ 15% and 30% of inter-
nalized pAntp–PAS and PAS–pAntp, respectively, reaching the cytosol.
Membrane active peptides, such as CPPs, often perturb and weaken
lipid bilayers [4]. Thus, a potential source of error is that the homogeni-
zation step would result in lysis of the weakened endosomal mem-
branes, leading to release of entrapped CPPs and overestimation of
their cytosolic delivery. As a control, HeLa cells were treated with
70 kDa neutral dextran-tetramethylrhodamine, alone or with non-
covalently attached CPPs, and FCS was used to quantify the amount of
dextran in the cytosolic fraction. In all cases, leakage of the 70 kDa dex-
tran from endosomes to the cytosol was negligible (Supplementary
Fig. S7A), demonstrating that the homogenization protocol used here
does not result in lysis of CPP-entrapping endosomes.
Another concern is that following escape from endocytic compart-
ments, CPPs bind to intracellular membranes and are then removed
by the ultracentrifugation step leading to an underestimation of the cy-
tosolic delivery efﬁciency. Therefore, as a control, Alexa 488-labeled
CPPs were added to HeLa cell homogenates, and FCS was used to
Fig. 3. Intracellular distribution and degradation of CPPs. 1 × 106 HeLa cells were treated with 1 μM Alexa 488-labeled CPPs for 2 h. Following peptide incubation, cells were washed,
trypsinized and sorted by FACS according to intracellular ﬂuorescence signal. FCS was then used to measure (A) the amount of CPPs in the cytosolic fraction (isolated by
homogenization of the cells followed by ultracentrifugation), or (B) the amount of CPPs that is degraded intracellularly, both relative to the amount of peptide taken up by the cells
(S.E., n = 3).
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ultracentrifugation. For each of the CPPs, all of the peptide added to
the homogenate was recovered in the cytosolic fraction (Supplementa-
ry Fig. S7B), indicating that loss of cytosolic CPPs due to binding to
intracellular membranes is negligible.
Thus coupling of pAntp to PAS not only substantially enhances cellu-
lar uptake by endocytosis (Figs. 1 and 2), but also dramatically increases
endosomal escape and cytosolic localization of the peptide (Fig. 3A).
Similar effects of PAS on the localization patterns of the octaarginine
CPP in HeLa cells were observed by confocal microscopy [23].
3.4. Intracellular degradation of CPPs
Another important consideration is the metabolic stability of CPPs.
On the one hand, CPPs need to remain intact long enough to efﬁciently
deliver their cargoes to intracellular target sites. On the other hand, deg-
radation of CPPs ensures release of the chemically conjugated cargoes,
minimizes the risk of unforeseen effects of the peptide, and eliminates
the possibility of the peptide-cargo conjugate ‘leaking back’ to the
extracellular environment. Consequently, a balance needs to be struck
between avoiding premature cleavage of the CPP and freeing the
cargo and clearing the peptide once the cargo has been delivered.
To assess the suitability of FACS–FCS for quantifying CPP degrada-
tion, mixtures of Alexa 488-labeled PAS–pAntp and free Alexa 488
dye, at different molar ratios, were added to HeLa cell lysates. The FCS
autocorrelation curves were then ﬁt to a multiple-component function
describing the diffusion of particles with different sizes (Eq. (3)) to de-
termine the fractional populations of CPP and dye in the lysate. The re-
sults are summarized in Supplementary Fig. S8, showing excellent
agreement between the experimentally measured CPP and dye frac-
tional populations in the lysates and the CPP and dye molar ratios in
the mixtures added to the lysates.
Following CPP incubation, the cells were washed, trypsinized and
sorted by FACS according to intracellular ﬂuorescence signal. The CPP-
positive cells were then lysed, and the autocorrelation data from the
cell lysates was ﬁt to Eq. (3) to determine the fractions of CPPs that
are degraded intracellularly (Fig. 3B). The results show that nearly 90%
of intracellular pAntp is degraded. Similar extensive degradation of
pAntp following cellular uptake has been reported by others [41,42].
However, coupling of pAntp to PAS substantially reduces the intracellu-
lar degradation, with over 70% of internalized PAS–pAntp remaining in-
tact. Interestingly, the decrease in degradation correlateswith increased
cytosolic delivery efﬁciency (Fig. 3A), indicating that escape from
the endosomal pathway, following cellular uptake, protects the PAS-coupled CPPs from degradation. These results identify endocytic
compartments as the major site of degradation, which is supported by
previous studies where lysosomal protease inhibitors were found to
inhibit the intracellular degradation of pAntp [43]. Our results also sug-
gest that once the PAS-coupled CPPs trafﬁc to the cytosol, they rapidly
localize to proteolytically privileged sites where they are shielded
from cytoplasmic proteases [42].
3.5. CPP toxicity threshold
Unlike current methods for measuring CPP uptake, the FACS–FCS
approach can also be used to study the cytotoxic effects of CPPs or
their cargoes and to accurately determine the maximum tolerable
amounts for the cell.
Following incubation of HeLa cells with the CPP that exhibited the
highest uptake efﬁciency, PAS–pAntp, cells were sorted into popula-
tions according to peptide uptake. These populations were further
sorted into live/dead subpopulations using DAPI/PI staining. Cell viabil-
ity/toxicitywas then determinedbyquantifying the fractions of the live/
dead subpopulations relative to the total number of cells in that popula-
tion. Finally, cell viability was plotted as a function of the amount of
PAS–pAntp taken up by the cells in the total population (Fig. 4).
Plasma membrane disruptions often spontaneously and rapidly re-
seal [44]. Thus, a potential concern is that transient membrane disrup-
tion due to the CPPs would be undetected by our cell viability/toxicity
protocol. To determinewhether the Alexa 488-labeled PAS–pAntp tem-
porarily disrupts the plasmamembrane during the course of peptide ex-
posure, we compared the cell viability measured using DAPI/PI staining
after sorting by FACS (i.e. our original protocol) vs staining during pep-
tide exposure. As summarized in Supplementary Fig. S9, DAPI/PI stain-
ing during peptide exposure rather than after sorting did not alter the
measured cell viabilities, indicating that exposure to Alexa 488-PAS–
pAntp does not transiently disrupt the cell membrane. The FACS–FCS
experimental approach therefore enables determination of the toxicity
threshold of CPPs or their cargoes, which is a key parameter in assessing
suitability for drug delivery.
The presence of cargo is likely to inﬂuence not only the mechanism
of internalization of CPPs, but also their cytotoxic effects. Cargo charac-
teristics such as size, charge and conjugationmethodology have been all
been shown to affect CPP cytotoxicity [7,45,46]. Given that ﬂuorescent
dyes are often highly hydrophobic molecules that interact with cellular
membranes, the presence of these ﬂuorophore cargoes would be
expected to enhance the cytotoxic effects of CPPs relative to the
peptide alone. We are currently conducting follow-up studies to fully
Fig. 4. Cell viability as a function of amount of internalized CPP. 1 × 106 HeLa cells were
treated with 1 μM Alexa 488-labeled PAS–pAntp for 2–4 h. Following peptide incubation,
cells were washed, trypsinized and sorted using FACS according to intracellular
ﬂuorescence signal. Populations of cells that took up peptide were then stained with
DAPI/PI (1 μM for 10 min) and sorted further into live/dead subpopulations, using the
DAPI (live cells) and PI (dead cells) signals. Finally, the fractions of the live/dead
subpopulations were determined relative to the total number of cells in that population,
and FCS was used to measure the precise amount of internalized CPP in the total
population (S.E., n = 3).
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well as coupling strategies, on the cytotoxicity of CPPs.
4. Conclusions
The rapid and technically straightforward FACS–FCS experimental
approach directly, accurately and precisely measures the number of
moles of CPPs per cell down to the low nanomolar range, which is the
expected physiological range for CPP uptake. From this the CPP uptake
efﬁciency can be determined. FACS–FCS can also delineate the contribu-
tion of active (e.g. endocytosis) and passive (energy-independent, e.g.
pore-formation) processes to the cellular internalization mechanism.
In the case of an active uptake mechanism, the approach can be used
in conjunction with endocytosis inhibitors to determine the contribu-
tion of different endocytic routes to the uptake. FACS–FCS readily differ-
entiates CPPs that localize to the cytosol from those trapped in
endocytic compartments, and in turn measures the cytosolic delivery
efﬁciency of the peptides. The approach can also be applied to measure
the cytotoxicity threshold of CPPs through live/dead cell counts at the
FACS step. Finally, the diffusion measurements by FCS report on the
fraction of peptide that is degraded or aggregated intracellularly, or
bound to an intracellular structure. Thus, FACS–FCS can be used to as-
sess all the major properties of CPPs that are important for their drug
delivery applications. Although we use the experimental approach
here to quantify intracellular CPPs, it can readily be applied to all bio-
molecules (proteins, peptides, nucleic acids, drugs or nanoparticles)
that are either expressed in the cell or introduced exogenously and
transported across the plasma membrane.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2016.03.023.
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